EUREKARE
eureKARE is focused on financing and building biotechnology companies in the cutting-edge fields of microbiome and synthetic biology.
EUREKARE
Industry:
Biotechnology Finance Financial Services
Founded:
2020-01-01
Status:
Active
Email Addresses:
[email protected]
Total Funding:
60 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome
Current Employees Featured
Founder
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-01-04 | DNA Script | eureKARE investment in Series C - DNA Script | 200 M USD |
2021-11-25 | Gynov | eureKARE investment in Corporate Round - Gynov | N/A |